| 177Lu | Lutetium-177 |
| CTCAE | Common Terminology Criteria for Adverse Events |
| G-CSF | Granulocyte-colony stimulating factor |
| NET | Neuroendocrine tumor |
| PBSC | Peripheral blood stem-cells collection |
| PRRT | Peptide receptor radionuclide therapy |
| 177Lu | Lutetium-177 |
| CTCAE | Common Terminology Criteria for Adverse Events |
| G-CSF | Granulocyte-colony stimulating factor |
| NET | Neuroendocrine tumor |
| PBSC | Peripheral blood stem-cells collection |
| PRRT | Peptide receptor radionuclide therapy |